Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	9.16e-10	16	143	6	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.05e-09	19	143	6	GO:0032394
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF5 ARHGEF11 TBC1D3C TBC1D3B CCDC88C DENND4B HERC1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F PSD4	4.00e-09	507	143	19	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF5 ARHGEF11 TBC1D3C TBC1D3B CCDC88C DENND4B HERC1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F PSD4	4.00e-09	507	143	19	GO:0030695
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF11 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.39e-08	279	143	14	GO:0005096
GeneOntologyMolecularFunction	MHC protein binding	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.62e-06	58	143	6	GO:0042287
GeneOntologyMolecularFunction	immune receptor activity	EBI3 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.53e-05	165	143	8	GO:0140375
GeneOntologyMolecularFunction	enzyme regulator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF5 ARHGEF11 TBC1D3C TBC1D3B ITIH2 CCDC88C DENND4B A2ML1 AKAP11 HERC1 TBC1D3I TBC1D3G NOTCH1 TP53 TBC1D3K TBC1D3F PSD4	6.79e-05	1418	143	24	GO:0030234
GeneOntologyMolecularFunction	enzyme activator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF11 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	2.67e-04	656	143	14	GO:0008047
GeneOntologyMolecularFunction	molecular function activator activity	TBC1D3E RIN3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 ARHGEF11 TBC1D3C TBC1D3B UCN2 CSF2 EBI3 TBC1D3I TBC1D3G NOTCH1 TP53 TBC1D3K TBC1D3F SECTM1	5.06e-04	1233	143	20	GO:0140677
GeneOntologyMolecularFunction	molecular adaptor activity	CNKSR1 TRIM25 PPRC1 DLGAP4 BCL9 SHANK3 KSR1 GAS2L2 SHARPIN OTUD4 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 EPN1 KIR3DL2 UTF1 NOTCH1 YTHDF3 DNMT3B	6.64e-04	1356	143	21	GO:0060090
GeneOntologyMolecularFunction	cadherin binding	TRIM25 VASN RTN4 FXYD5 CDH23 CBL TNKS1BP1 GOLGA3 NOTCH3	7.67e-04	339	143	9	GO:0045296
GeneOntologyMolecularFunction	hyaluronic acid binding	ITIH2 NCAN IMPG2	1.15e-03	29	143	3	GO:0005540
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RIN3 ARHGEF5 ARHGEF11 CCDC88C DENND4B HERC1 PSD4	1.40e-03	231	143	7	GO:0005085
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGEF5 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.25e-11	109	142	12	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGEF5 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.28e-07	244	142	12	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGEF5 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	3.65e-06	335	142	12	GO:0043087
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	TRIM25 RTN4 KIR2DS2 FCHO1 OTUD4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.30e-05	615	142	15	GO:0002764
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGEF5 TBC1D3C TBC1D3B TBC1D3I TBC1D3G EIF2AK3 TBC1D3K TBC1D3F	4.24e-05	499	142	13	GO:0051345
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	CNKSR1 ARHGAP23 ARHGEF5 RTN4 ARHGEF11 CBL CCDC88C KSR1 HEG1 DENND4B NOTCH1 NOTCH2 PSD4	9.08e-05	538	142	13	GO:0007264
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	ARHGAP23 ARHGEF5 RTN4 ARHGEF11 CBL HEG1 DENND4B NOTCH1 NOTCH2 PSD4	1.06e-04	333	142	10	GO:0051056
GeneOntologyBiologicalProcess	cellular response to tumor cell	NOTCH1 NOTCH2	1.41e-04	3	142	2	GO:0071228
Domain	TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	2.59e-12	49	140	10	SM00164
Domain	RabGAP-TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	6.00e-12	53	140	10	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	8.88e-12	55	140	10	IPR000195
Domain	TBC_RABGAP	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	8.88e-12	55	140	10	PS50086
Domain	-	VASN KIR2DS2 REL EBI3 NFATC4 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 IGSF23 SECTM1	2.35e-08	663	140	21	2.60.40.10
Domain	Ig-like_fold	VASN KIR2DS2 REL EBI3 NFATC4 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 IGSF23 SECTM1	6.86e-08	706	140	21	IPR013783
Domain	ig	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.96e-07	190	140	11	PF00047
Domain	Immunoglobulin	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.96e-07	190	140	11	IPR013151
Domain	DUF3454	NOTCH1 NOTCH2 NOTCH3	4.12e-07	3	140	3	PF11936
Domain	DUF3454_notch	NOTCH1 NOTCH2 NOTCH3	4.12e-07	3	140	3	IPR024600
Domain	DUF3454	NOTCH1 NOTCH2 NOTCH3	4.12e-07	3	140	3	SM01334
Domain	IG	KIR2DS2 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.45e-07	421	140	15	SM00409
Domain	Ig_sub	KIR2DS2 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.45e-07	421	140	15	IPR003599
Domain	Ig-like_dom	KIR2DS2 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 IGSF23	1.20e-06	503	140	16	IPR007110
Domain	Notch	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	IPR008297
Domain	NODP	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	PF07684
Domain	Notch_NODP_dom	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	IPR011656
Domain	Notch_NOD_dom	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	IPR010660
Domain	NOD	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	PF06816
Domain	NOD	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	SM01338
Domain	NODP	NOTCH1 NOTCH2 NOTCH3	1.64e-06	4	140	3	SM01339
Domain	LNR	NOTCH1 NOTCH2 NOTCH3	4.08e-06	5	140	3	PS50258
Domain	IG_LIKE	KIR2DS2 NCAN ALPK3 FCRLB ROBO2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 IGSF23	4.31e-06	491	140	15	PS50835
Domain	Notch_dom	NOTCH1 NOTCH2 NOTCH3	1.41e-05	7	140	3	IPR000800
Domain	Notch	NOTCH1 NOTCH2 NOTCH3	1.41e-05	7	140	3	PF00066
Domain	NL	NOTCH1 NOTCH2 NOTCH3	1.41e-05	7	140	3	SM00004
Domain	EGF	CD248 VASN HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	4.60e-05	126	140	7	PF00008
Domain	EGF_Ca-bd_CS	CD248 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	9.00e-05	97	140	6	IPR018097
Domain	EGF_CA	CD248 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	1.01e-04	99	140	6	PS01187
Domain	EGF_1	CD248 VASN MUC12 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3 IMPG2	1.33e-04	255	140	9	PS00022
Domain	EGF-type_Asp/Asn_hydroxyl_site	CD248 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	1.47e-04	106	140	6	IPR000152
Domain	EGF-like_CS	CD248 VASN MUC12 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3 IMPG2	1.58e-04	261	140	9	IPR013032
Domain	FAM53	FAM53A FAM53C	1.67e-04	3	140	2	IPR029356
Domain	FAM53	FAM53A FAM53C	1.67e-04	3	140	2	PF15242
Domain	EGF_2	CD248 VASN MUC12 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3 IMPG2	1.77e-04	265	140	9	PS01186
Domain	EGF_CA	CD248 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	3.16e-04	122	140	6	SM00179
Domain	EGF-like_Ca-bd_dom	CD248 HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	3.45e-04	124	140	6	IPR001881
Domain	EGF_3	CD248 VASN HEG1 NCAN NOTCH1 NOTCH2 NOTCH3 IMPG2	4.01e-04	235	140	8	PS50026
Domain	EGF_CA	CD248 HEG1 NOTCH1 NOTCH2 NOTCH3	4.71e-04	86	140	5	PF07645
Domain	SEA	MUC16 MUC12 IMPG2	5.72e-04	22	140	3	PF01390
Domain	EGF-like_dom	CD248 VASN HEG1 NCAN NOTCH1 NOTCH2 NOTCH3 IMPG2	5.87e-04	249	140	8	IPR000742
Domain	SEA	MUC16 MUC12 IMPG2	6.54e-04	23	140	3	PS50024
Domain	SEA_dom	MUC16 MUC12 IMPG2	6.54e-04	23	140	3	IPR000082
Domain	ENTH	EPN3 EPN1	8.20e-04	6	140	2	PF01417
Domain	ASX_HYDROXYL	HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	9.37e-04	100	140	5	PS00010
Domain	hEGF	NOTCH1 NOTCH2 NOTCH3	1.18e-03	28	140	3	PF12661
Domain	ENTH	EPN3 EPN1	1.94e-03	9	140	2	PS50942
Domain	ENTH	EPN3 EPN1	1.94e-03	9	140	2	SM00273
Domain	EGF	CD248 VASN HEG1 NCAN NOTCH1 NOTCH2 NOTCH3	1.99e-03	235	140	7	SM00181
Domain	RHD_dimer	REL NFATC4	2.41e-03	10	140	2	IPR032397
Domain	RHD_dimer	REL NFATC4	2.41e-03	10	140	2	PF16179
Domain	REL_1	REL NFATC4	2.41e-03	10	140	2	PS01204
Domain	ENTH	EPN3 EPN1	2.41e-03	10	140	2	IPR013809
Domain	-	REL NFATC4	2.41e-03	10	140	2	2.60.40.340
Domain	NFkB/Dor	REL NFATC4	2.41e-03	10	140	2	IPR000451
Domain	RHD_DNA_bind_dom	REL NFATC4	2.41e-03	10	140	2	IPR011539
Domain	RHD_DNA_bind	REL NFATC4	2.41e-03	10	140	2	PF00554
Domain	REL_2	REL NFATC4	2.41e-03	10	140	2	PS50254
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3E TBC1D3 TBC1D3H TBC1D3L ARHGAP23 TBC1D3C TBC1D3B GAS2L2 TBC1D3I TBC1D3G TBC1D3K	2.06e-10	99	107	11	M46448
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	SH3BP2 CSF2 NFATC4 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	4.93e-10	137	107	12	M5669
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	2.06e-08	88	107	9	M16004
Pathway	REACTOME_DAP12_INTERACTIONS	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.19e-06	54	107	6	MM14871
Pathway	REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3	NOTCH1 NOTCH2 NOTCH3	4.21e-06	5	107	3	M27411
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM	NOTCH1 NOTCH2 NOTCH3	8.36e-06	6	107	3	M27068
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 NOTCH1 NOTCH2 NOTCH3	1.24e-05	68	107	6	M27303
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	1.38e-05	41	107	5	M13519
Pathway	KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION	NOTCH1 NOTCH2 NOTCH3	6.71e-05	11	107	3	M47865
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380	NOTCH1 NOTCH2 NOTCH3	8.90e-05	12	107	3	M47532
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381	NOTCH1 NOTCH2 NOTCH3	8.90e-05	12	107	3	M47533
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC12 NCAN NOTCH1 NOTCH2 NOTCH3	1.07e-04	143	107	7	M27275
Pathway	KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY	NOTCH1 NOTCH2 NOTCH3	1.15e-04	13	107	3	M47423
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382	NOTCH1 NOTCH2 NOTCH3	1.15e-04	13	107	3	M47534
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12	2.22e-04	16	107	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12	2.68e-04	17	107	3	M27412
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	NOTCH1 NOTCH2 NOTCH3	3.19e-04	18	107	3	M614
Pathway	REACTOME_DAP12_INTERACTIONS	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DS1	4.01e-04	46	107	4	M27151
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN	TNKS1BP1 CNOT4 TP53	5.12e-04	21	107	3	M27634
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	NOTCH1 NOTCH3	5.62e-04	5	107	2	MM14733
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	5.65e-04	135	107	6	MM14781
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR3DL1 KIR3DL2	6.06e-04	190	107	7	M8240
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12	6.74e-04	23	107	3	M556
Pathway	KEGG_DORSO_VENTRAL_AXIS_FORMATION	NOTCH1 NOTCH2 NOTCH3	7.66e-04	24	107	3	M11190
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12	9.73e-04	26	107	3	M27483
Pathway	PID_NOTCH_PATHWAY	CBL NOTCH1 NOTCH2 NOTCH3	1.04e-03	59	107	4	M17
Pathway	WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING	NOTCH1 NOTCH2 NOTCH3	1.09e-03	27	107	3	M39545
Pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	NOTCH1 NOTCH3	1.17e-03	7	107	2	MM14734
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	NOTCH1 NOTCH2 NOTCH3	1.21e-03	28	107	3	M6177
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	4.15e-27	11	144	11	16863688
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.50e-24	14	144	11	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.50e-24	14	144	11	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.50e-24	14	144	11	15896204
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.59e-24	15	144	11	20082646
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.59e-24	15	144	11	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.59e-24	15	144	11	19926642
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.59e-24	15	144	11	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.59e-24	15	144	11	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	19897003
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	19309280
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	20652381
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	17868255
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	20331834
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	18668235
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	19527230
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	19279038
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.78e-23	16	144	11	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	20878400
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	20483367
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	19761533
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	20650299
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	20173792
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.03e-23	17	144	11	19218127
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	7.06e-23	12	144	10	20371502
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.29e-22	18	144	11	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.29e-22	18	144	11	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.29e-22	18	144	11	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.29e-22	18	144	11	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.29e-22	18	144	11	19046302
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.05e-22	19	144	11	20600442
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.05e-22	19	144	11	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.05e-22	19	144	11	18778326
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.05e-22	19	144	11	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.75e-22	20	144	11	20193031
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.41e-21	21	144	11	19861144
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DL2	2.76e-21	10	144	9	12559621
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.82e-21	22	144	11	20492596
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	3.18e-21	15	144	10	17498266
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	8.44e-21	16	144	10	16403292
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.51e-20	11	144	9	19664392
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.04e-20	17	144	10	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL2 KIR3DS1	2.04e-20	17	144	10	20173784
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	2.04e-20	17	144	10	19169284
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	4.58e-20	18	144	10	20200544
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	4.58e-20	18	144	10	20210918
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	6.04e-20	12	144	9	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	6.04e-20	12	144	9	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.04e-20	12	144	9	20137308
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DL2 KIR3DS1	7.09e-20	8	144	8	9430221
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.35e-19	29	144	11	20082482
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.92e-19	20	144	10	20426625
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.96e-19	13	144	9	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.96e-19	13	144	9	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.96e-19	13	144	9	18687225
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	5.46e-19	14	144	9	19421224
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL4 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.46e-19	14	144	9	18945962
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	6.36e-19	9	144	8	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.36e-19	9	144	8	8662091
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.36e-18	15	144	9	19850842
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.36e-18	15	144	9	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.36e-18	15	144	9	19493232
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.59e-18	35	144	11	19683555
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	1.16e-17	11	144	8	18830515
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4	1.80e-17	7	144	7	11169255
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1	1.80e-17	7	144	7	9430220
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.46e-17	12	144	8	17490516
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DS1	1.44e-16	8	144	7	17200871
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	1.44e-16	8	144	7	18681957
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	1.44e-16	8	144	7	15730517
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	6.44e-16	9	144	7	18340360
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DS1	4.54e-15	6	144	6	17882223
Pubmed	Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.16e-14	7	144	6	12618911
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1 KIR3DL2	3.16e-14	7	144	6	14607943
Pubmed	Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.16e-14	7	144	6	15748957
Pubmed	Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.16e-14	7	144	6	26928464
Pubmed	Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.	KIR2DS2 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL2 KIR3DS1	3.77e-13	9	144	6	18074414
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1	9.40e-13	10	144	6	21206914
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.13e-12	5	144	5	18755860
Pubmed	KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1	1.13e-12	5	144	5	27893413
Pubmed	Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.	KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2	1.13e-12	5	144	5	7716543
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4	1.13e-12	5	144	5	10424431
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.13e-12	5	144	5	16112031
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1	6.79e-12	6	144	5	20528243
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3E TBC1D3 TBC1D3H TBC1D3D ARHGAP23 TBC1D3B KSR1 TBC1D3G TBC1D3F	2.44e-11	74	144	9	16625196
Pubmed	Distribution of KIR genes in the Czech population.	KIR2DL1 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	1.41e-10	9	144	5	18186800
Pubmed	[Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups].	KIR2DL1 KIR2DL4 KIR3DL1 KIR3DL2	2.82e-10	4	144	4	18718052
Pubmed	Polymorphism and domain variability of human killer cell inhibitory receptors.	KIR2DL3 KIR2DL4 KIR3DL1 KIR3DS1	2.82e-10	4	144	4	9059894
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1	2.82e-10	4	144	4	18269867
Pubmed	Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	2.82e-10	4	144	4	18632158
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	2.82e-10	4	144	4	26542066
Pubmed	High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.	KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1	2.82e-10	4	144	4	19522772
Pubmed	Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.	KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1	2.82e-10	4	144	4	23354323
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4	1.40e-09	5	144	4	19410616
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.	KIR2DL1 KIR2DS3 KIR3DL1 KIR3DS1	1.40e-09	5	144	4	16508981
Interaction	KIR2DL2 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1 KIR3DS1	1.40e-10	13	136	6	int:KIR2DL2
Interaction	KIR2DS2 interactions	KIR2DS2 MUC5B KIR2DL2 KIR2DS1 KIR2DS3 KIR3DL1	1.65e-07	37	136	6	int:KIR2DS2
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 EIF2AK3	1.86e-07	20	136	5	int:KIR2DS3
Interaction	KIR3DL1 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1	1.35e-06	13	136	4	int:KIR3DL1
Interaction	TOP3B interactions	EPN3 USP34 STK36 RIN3 TRIM25 MYO1C PPRC1 GTSE1 TNRC6B BCL9 ARHGEF11 HES2 CCDC88C TLK1 HEG1 TMEM132A OTUD4 CACNA1H TNKS1BP1 WDFY3 HERC1 CRAMP1 NOTCH1 YTHDF3 NOTCH2 TP53 PRRC2B	1.56e-06	1470	136	27	int:TOP3B
Interaction	PPP1R13L interactions	TRIM25 GTSE1 SHANK3 CBX6 SOHLH1 TP53 PRRC2B	2.20e-06	88	136	7	int:PPP1R13L
Interaction	CNOT6L interactions	VASN TNRC6B TNKS1BP1 TMEM131 CNOT4 YTHDF3 PRRC2B	3.19e-06	93	136	7	int:CNOT6L
Interaction	JAG2 interactions	TRIM25 RPN1 VASN SHANK3 NOTCH1 NOTCH2 NOTCH3	9.74e-06	110	136	7	int:JAG2
Interaction	DTX2 interactions	EPN3 USP34 TRIM25 AKAP8 BCL9 ARHGEF11 SOHLH1 TASOR NOTCH1 NOTCH2 NOTCH3	1.52e-05	330	136	11	int:DTX2
Interaction	ZCCHC2 interactions	SHANK3 OTUD4 YTHDF3 TP53	1.59e-05	23	136	4	int:ZCCHC2
Interaction	DNER interactions	TRIM25 PDLIM7 NOTCH1	1.64e-05	8	136	3	int:DNER
Interaction	KIR2DL1 interactions	KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1	3.58e-05	28	136	4	int:KIR2DL1
Interaction	TRAPPC10 interactions	TRIM25 PDLIM7 ADGRB1 CBL NOTCH1 DMTN	3.75e-05	92	136	6	int:TRAPPC10
Interaction	CNOT7 interactions	TNRC6B CBL TNKS1BP1 TMEM131 CNOT4 YTHDF3 PRRC2B	4.65e-05	140	136	7	int:CNOT7
Interaction	GAS5 interactions	TRIM25 YTHDF3 TP53	4.77e-05	11	136	3	int:GAS5
Interaction	ARMH4 interactions	ELAPOR2 TRIM25 TP53	4.77e-05	11	136	3	int:ARMH4
Interaction	PUM2 interactions	TRIM25 TNRC6B CBX6 OTUD4 YTHDF3 TP53 PRRC2B	5.56e-05	144	136	7	int:PUM2
Interaction	PTK6 interactions	TRIM25 REL FCHO1 PRDM6 YTHDF3 TP53	7.46e-05	104	136	6	int:PTK6
Interaction	CNOT4 interactions	KDM5C TNRC6B TNKS1BP1 CNOT4 YTHDF3	7.76e-05	65	136	5	int:CNOT4
Interaction	DDX11 interactions	USP43 CDH23 WDFY3 TP53 PRRC2B	9.64e-05	68	136	5	int:DDX11
Interaction	YWHAE interactions	EPN3 TICRR TRIM25 AKAP8 PDLIM7 ARHGEF5 GTSE1 USP43 CBL FAM53C SHANK3 CCDC88C KSR1 TLK1 AKAP11 CNOT4 GOLGA3 TP53 DMTN TBC1D3F PSD4	1.03e-04	1256	136	21	int:YWHAE
Interaction	IGSF5 interactions	NOTCH1 NOTCH2 NOTCH3	1.04e-04	14	136	3	int:IGSF5
Interaction	NOTCH3 interactions	CBL SHANK3 NOTCH1 NOTCH2 NOTCH3 CTXN1	1.18e-04	113	136	6	int:NOTCH3
Interaction	DLL1 interactions	EPN1 NOTCH1 NOTCH2 NOTCH3	1.23e-04	38	136	4	int:DLL1
Interaction	CSDE1 interactions	RIN3 TRIM25 VASN TNRC6B OTUD4 BICC1 YTHDF3 TP53 PRRC2B	1.36e-04	284	136	9	int:CSDE1
Interaction	ANKRD17 interactions	TNRC6B GAS2L2 CBX6 OTUD4 TNKS1BP1 CNOT4 YTHDF3 PRRC2B	1.52e-04	226	136	8	int:ANKRD17
Interaction	OTUD1 interactions	TRIM25 RPN1 TNRC6B AAAS NOTCH2 TP53 PRRC2B	1.57e-04	170	136	7	int:OTUD1
Interaction	KIF1C interactions	TRIM25 FAM53C KSR1 ROBO2 YTHDF3 TP53	1.65e-04	120	136	6	int:KIF1C
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.48e-15	79	144	11	19q13.4
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP23 TBC1D3C TBC1D3B GAS2L2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.90e-15	149	144	13	chr17q12
Cytoband	17q12	TBC1D3 TBC1D3H ARHGAP23 TBC1D3C TBC1D3B GAS2L2 TBC1D3F	3.02e-08	99	144	7	17q12
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	FXYD5 MYPOP DACT3 DMRTC2 KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 EPN1 KIR3DL2 IGSF23	3.99e-04	1192	144	12	chr19q13
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.15e-22	18	87	11	620
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD248 KIR2DS2 GYPC KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2	2.91e-06	394	87	11	471
GeneFamily	CD molecules\|Mucins	MUC16 MUC5B MUC12	1.34e-04	21	87	3	648
GeneFamily	PDZ domain containing	CNKSR1 ARHGAP23 PDLIM7 ARHGEF11 SHANK3	8.35e-04	152	87	5	1220
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR3DL1	2.27e-10	49	142	8	M40909
Coexpression	GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	KIR2DS2 PROX2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 NOTCH1	9.64e-06	190	142	8	M4662
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	EPN3 CNKSR1 BCL9 PTCH2 TASOR NOTCH1 DNMT3B SECTM1	1.40e-05	200	142	8	M7256
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_UP	PDLIM7 SH3BP2 FXYD5 KIR2DL1 KIR2DL3 ASB2 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	1.86e-05	343	142	10	MM1059
Coexpression	FUKUSHIMA_TNFSF11_TARGETS	NOTCH1 NOTCH2 NOTCH3	8.28e-05	16	142	3	MM1296
Coexpression	FUKUSHIMA_TNFSF11_TARGETS	NOTCH1 NOTCH2 NOTCH3	8.28e-05	16	142	3	M2207
Coexpression	GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP	PDLIM7 TNRC6B CBL ZNF692 KSR1 AAAS ALPK3	9.35e-05	194	142	7	M9723
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN	DLGAP4 BCL9 FCHO1 KSR1 EBI3 GYPC CACNA1H	1.10e-04	199	142	7	M3738
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	CD248 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR3DS1	1.10e-04	199	142	7	M9885
Coexpression	GSE20715_WT_VS_TLR4_KO_LUNG_DN	USP34 MAN2C1 MUC5B SHANK3 CCDC88C DMBT1 WNK4	1.10e-04	199	142	7	M4350
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	USP34 MAN2C1 SH3BP2 BCL9 GYPC ASB2 IGSF23	1.13e-04	200	142	7	M5069
Coexpression	GSE11924_TH1_VS_TH17_CD4_TCELL_UP	TRIM25 SH3BP2 REL SHANK3 CSF2 PROX2 TASOR	1.13e-04	200	142	7	M3161
Coexpression	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP	MAN2C1 ARHGAP23 CBX6 DENND4B AFF1 TMEM131 CRAMP1	1.13e-04	200	142	7	M3850
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL	KIR2DL1 KIR2DL3 KIR3DL1	1.20e-04	18	142	3	M45763
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F DNMT3B	2.47e-10	90	133	10	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 MAN2C1 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B CACNA1H TBC1D3G EIF2AK3 NOTCH1 NOTCH3 TBC1D3K TBC1D3F	2.76e-10	281	133	15	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 MAN2C1 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B CACNA1H TBC1D3G EIF2AK3 NOTCH1 NOTCH3 TBC1D3K TBC1D3F	2.76e-10	281	133	15	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGEF5 TBC1D3C TBC1D3B TBC1D3G DMTN TBC1D3K TBC1D3F	3.73e-07	242	133	11	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G DMTN TBC1D3K TBC1D3F	9.64e-07	213	133	10	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G DMTN TBC1D3K TBC1D3F	9.64e-07	213	133	10	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 MAN2C1 TBC1D3H TBC1D3L TBC1D3D VASN TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	5.65e-06	320	133	11	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	STK36 ELAPOR2 CNKSR1 TBC1D3 MAN2C1 TBC1D3H TBC1D3L MYO1C TBC1D3D PDLIM7 VASN ZNF692 TBC1D3C TBC1D3B SHANK3 NFATC4 CACNA1H TBC1D3G NOTCH2 PRRC2B TBC1D3K TBC1D3F	1.12e-04	1466	133	22	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 MAN2C1 TBC1D3H TBC1D3L TBC1D3D VASN ZNF692 TBC1D3C TBC1D3B SHANK3 NFATC4 TMEM132A CACNA1H HERC1 TBC1D3G NOTCH2 TBC1D3K TBC1D3F	1.32e-04	1075	133	18	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|normal_Lymph_Node / Location, Cell class and cell subclass	RIN3 USP43 REL CSF2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.26e-08	196	140	9	00ab4a1547752d419aa720b39b94a4ab2ede963a
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	RIN3 USP43 REL CSF2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.37e-08	198	140	9	75e94298bf03d755fef46df685437d0d29fdbca9
ToppCell	BL-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RIN3 HEG1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.05e-07	196	140	8	cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 PDLIM7 OLFML2B GYPC ROBO2 ASB2 PRDM6 CTXN1	2.22e-07	198	140	8	63f7d25201613bd3404c28fb936954190bca91d3
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 PDLIM7 OLFML2B GYPC ROBO2 ASB2 PRDM6 CTXN1	2.22e-07	198	140	8	a73534b6ca202c277a70a52281d5b97a3e6cb8ef
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 PDLIM7 OLFML2B GYPC ROBO2 ASB2 PRDM6 CTXN1	2.22e-07	198	140	8	d1e1bdd36c84e1bac21ba137f018defe98456a8c
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RIN3 REL CSF2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.40e-07	200	140	8	48ca9269ee3962d13408fef12b5be120759eac52
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|367C / Donor, Lineage, Cell class and subclass (all cells)	CCDC88C PRRT3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 CNOT4	1.24e-06	172	140	7	6379ae0aca9007c3a8a87e3330908fc90961ad3f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 ITIH2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.24e-06	172	140	7	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RIN3 OLFML2B GYPC KIR2DL1 KIR2DL4 KIR3DL1 KIR3DL2	2.16e-06	187	140	7	e5713a7bda53d1d5178ab4e0dbadc2292b6005bc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 DACT3 ROBO2 CACNA1H ASB2 PRDM6 NOTCH3	2.32e-06	189	140	7	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PDLIM7 PTCH2 ROBO2 ASB2 PRDM6 NOTCH3 CTXN1	2.32e-06	189	140	7	f75cebd4c3e54e297557449ba67ccc8d1a2a14f5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 DACT3 ROBO2 CACNA1H ASB2 PRDM6 NOTCH3	2.32e-06	189	140	7	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 DACT3 ROBO2 PRDM6 BICC1 NOTCH2 NOTCH3	2.32e-06	189	140	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FCHO1 PROX2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.66e-06	193	140	7	91a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD248 PDLIM7 GYPC ROBO2 ASB2 PRDM6 CTXN1	2.66e-06	193	140	7	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD248 PDLIM7 GYPC ROBO2 ASB2 PRDM6 CTXN1	2.66e-06	193	140	7	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	metastatic_Brain-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	RIN3 REL KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.85e-06	195	140	7	184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD248 PDLIM7 OLFML2B GYPC ROBO2 PRDM6 CTXN1	3.05e-06	197	140	7	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	tumor_Lung-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	RIN3 REL KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.05e-06	197	140	7	e9fac2c923179b2b8b0500076421c6fb09960b56
ToppCell	390C-Lymphocytic-NK_cells\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RIN3 REL KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.15e-06	198	140	7	623e5ada1a54cd42c32a1519b84dbe782384ee0c
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|390C / Donor, Lineage, Cell class and subclass (all cells)	RIN3 REL KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.26e-06	199	140	7	f72db89fe7e511473fc849f8fadb8b6453ac8ae5
ToppCell	Transverse-T_cell-gd_T\|Transverse / Region, Cell class and subclass	RIN3 CD248 KIR2DL1 KIR2DL3 ASB2 KIR2DL4 KIR3DL2	3.26e-06	199	140	7	92554fddd887fe6c1c943ed704d4a02c999ba830
ToppCell	Transverse-(1)_T_cell-(17)_gd_T\|Transverse / shred on region, Cell_type, and subtype	RIN3 CD248 KIR2DL1 KIR2DL3 ASB2 KIR2DL4 KIR3DL2	3.26e-06	199	140	7	a3a29ed65881f1dcf09b2fec8788161ea3adef48
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KIAA0408 CD248 PDLIM7 OLFML2B ROBO2 ASB2 NOTCH3	3.37e-06	200	140	7	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CD248 OLFML2B VASN DACT3 ROBO2 PRDM6 BICC1	3.37e-06	200	140	7	54806080b5e97859ee6a4a9b4f19e22021c218f5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIAA0408 CD248 PDLIM7 OLFML2B VASN ASB2 NOTCH3	3.37e-06	200	140	7	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	(17)_gd_T\|World / shred on Cell_type and subtype	RIN3 KIR2DL1 KIR2DL3 ASB2 KIR2DL4 KIR3DL1 KIR3DL2	3.48e-06	201	140	7	7fcfe48758acf07cb3dda939ce589ae1518e41c9
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Medullary_Carcinoma-4\|TCGA-Breast / Sample_Type by Project: Shred V9	KSR1 CSF2 A2ML1 DMBT1 KIR2DL4 KIR3DL1	3.70e-06	131	140	6	1b467eefad0265cf6dba7831d4d597b8b8e69dd4
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TMPRSS9 CD248 PDLIM7 GYPC SLC49A3 CTXN1	7.47e-06	148	140	6	5729826e8d45bf995e2efa6707c49e264d12d112
ToppCell	368C-Lymphocytic-NK_cells\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 DMTN	8.07e-06	150	140	6	17b3ac5ddc47b9cba0a27b268d63a6e491b2b111
ToppCell	368C-Lymphocytic-NK_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 DMTN	1.05e-05	157	140	6	ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GTSE1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.30e-05	163	140	6	466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ELAPOR2 REL SHANK3 EBI3 TMEM132A UTF1	1.39e-05	165	140	6	c39f0479955c4e23921f7a450d3bc251a002200f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.54e-05	168	140	6	b4bb03efb601a61465260f93896c56861c588bef
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.54e-05	168	140	6	240ea32b64d86f9216785010d6b237d9adf052c9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.59e-05	169	140	6	e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 ADGRB1 HEG1 FCRLB DMBT1 BICC1	1.64e-05	170	140	6	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OLFML2B ADGRB1 DACT3 PRDM6 NOTCH2 NOTCH3	1.64e-05	170	140	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 CD248 OLFML2B NFATC4 DACT3 NOTCH3	1.94e-05	175	140	6	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	1.94e-05	175	140	6	8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-Activated_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PATL2 RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1	2.00e-05	176	140	6	6802ed40eb0f91674d4f0120a3d4888c8a2e9612
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HEG1 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.07e-05	177	140	6	0f2616a81f8fbede77c860b2126e3fa826672da3
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ITIH2 NFATC4 PRDM6 WNK4 BICC1 NOTCH2	2.13e-05	178	140	6	cda7695411655bd6d0ba69e5041ca7530a9dad3a
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CD248 OLFML2B VASN ROBO2 MMP11 NOTCH3	2.13e-05	178	140	6	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	ILEUM-non-inflamed-(1)_T_(gd)\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RIN3 GYPC KIR2DL1 KIR2DL4 KIR3DL1 KIR3DL2	2.27e-05	180	140	6	44c37644973c4fc555dc966f8cfe1f4f81fef300
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CD248 PDLIM7 TMEM132A ROBO2 MMP11 PRDM6	2.34e-05	181	140	6	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-mature_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PATL2 REL FCRLB KIR2DL1 KIR2DL3 KIR3DL1	2.49e-05	183	140	6	8746e6ecc6bf9e194cc9cdf9b07da63f0fcf8b5f
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ITIH2 NFATC4 PRDM6 WNK4 BICC1 NOTCH2	2.57e-05	184	140	6	235890e8b424f4386b6ea52d173d20a00898df73
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 OLFML2B VASN ADGRB1 DACT3 NOTCH3	2.57e-05	184	140	6	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDLIM7 OLFML2B VASN DACT3 PRDM6 NOTCH3	2.57e-05	184	140	6	603faafb7b289a3c0242c84fc800c050c8a092ea
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDLIM7 OLFML2B VASN DACT3 PRDM6 NOTCH3	2.57e-05	184	140	6	c350504bfe0ec31cd2fc2199de9b5fff151a8c5e
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD248 OLFML2B CACNA1H GRIN3A PRDM6 BICC1	2.65e-05	185	140	6	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 VASN NFATC4 CACNA1H ASB2 NOTCH3	2.65e-05	185	140	6	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 OLFML2B ROBO2 ASB2 PRDM6 BICC1	2.65e-05	185	140	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 VASN NFATC4 CACNA1H ASB2 NOTCH3	2.65e-05	185	140	6	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	2.73e-05	186	140	6	1590fe72badffc79f1d390deb3207116ac2281bb
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CSF2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.73e-05	186	140	6	e37e317e9770e35cb41137f51868d8b20ecd21d8
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	2.73e-05	186	140	6	e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM7 OLFML2B DACT3 ASB2 PRDM6 NOTCH3	2.73e-05	186	140	6	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 TNRC6B REL TMEM131 HERC1 EIF2AK3	2.90e-05	188	140	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 PDLIM7 ROBO2 ASB2 PRDM6 BICC1	2.90e-05	188	140	6	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 NOTCH1 PSD4	2.90e-05	188	140	6	9abd78970bbe4ed03b59a83da63bbd334712f605
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 NOTCH1 PSD4	2.90e-05	188	140	6	f7dc29dfec68236883469e848be5db34f5526d6b
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	PDLIM7 CBL ALPK3 CACNA1H ASB2 NOTCH3	2.90e-05	188	140	6	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 NOTCH1 PSD4	2.90e-05	188	140	6	5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	CCDC88C KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	2.99e-05	189	140	6	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	metastatic_Brain-T/NK_cells-NK\|metastatic_Brain / Location, Cell class and cell subclass	PATL2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.08e-05	190	140	6	50e937ba0600e1ac6215f056bb545dc1e8b28a76
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OLFML2B DACT3 CACNA1H ASB2 PRDM6 NOTCH3	3.08e-05	190	140	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-8\|TCGA-Lung / Sample_Type by Project: Shred V9	ADGRB1 KIR2DL3 KIR2DS4 KIR3DL1 TBC1D3K	3.17e-05	115	140	5	55a56828f86c004cd11d1a426a03e86246e949a3
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 NFATC4 DACT3 CACNA1H PRDM6 NOTCH3	3.17e-05	191	140	6	8597a8af294f24496c317d995f07eb5dcc25c13c
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PATL2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.17e-05	191	140	6	753deb090b7b78b4ef31604dbe5dbfc4dcf5184a
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PATL2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.17e-05	191	140	6	355f5bcb220d917163833dead0050fc756c7b260
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PATL2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.17e-05	191	140	6	337d7d7b89fe370e1fe005b9daad76c5dc3b8444
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 GYPC ASB2 NOTCH2 NOTCH3	3.17e-05	191	140	6	96ff4cfbdcaec4b8568f9482d732dddd399121d3
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	RIN3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 CRAMP1	3.17e-05	191	140	6	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	CCDC88C KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 CRAMP1	3.17e-05	191	140	6	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSF2 PTCH2 CACNA1H KIR2DL3 KIR2DL4 KIR3DL1	3.26e-05	192	140	6	930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell	normal_Pleural_Fluid-T/NK_cells-NK\|normal_Pleural_Fluid / Location, Cell class and cell subclass	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.26e-05	192	140	6	59dd4f5ae9f1cca78adf60b71661092ef09e6641
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 PDLIM7 DACT3 ASB2 PRDM6 NOTCH3	3.26e-05	192	140	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSF2 PTCH2 CACNA1H KIR2DL3 KIR2DL4 KIR3DL1	3.26e-05	192	140	6	c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 NFATC4 GYPC ASB2 NOTCH3	3.36e-05	193	140	6	18e11d515147accef9aee26e934b358b445e18e2
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	RIN3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2 CRAMP1	3.36e-05	193	140	6	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 NFATC4 GYPC ASB2 NOTCH3	3.36e-05	193	140	6	7766f495f2f945802ef9a5b994cd00bb64d0dfe3
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	GYPC KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.36e-05	193	140	6	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 NFATC4 GYPC ASB2 NOTCH3	3.36e-05	193	140	6	ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RIN3 SH3BP2 CDH23 CBL KSR1 NOTCH2	3.46e-05	194	140	6	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RIN3 SH3BP2 CDH23 CBL KSR1 NOTCH2	3.46e-05	194	140	6	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 GYPC ASB2 NOTCH2 NOTCH3	3.46e-05	194	140	6	3bff2e4eb16719ab7419b2f94c9c6e7302aa6629
ToppCell	lymphoid-NK_cell\|World / Lineage, cell class and subclass	RIN3 REL KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1	3.46e-05	194	140	6	4bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIN3 KIR2DL1 KIR2DL3 ASB2 KIR2DL4 KIR3DL2	3.46e-05	194	140	6	b5ad5f34d76efab51a1965d9173179818f412d32
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.46e-05	194	140	6	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_C\|343B / Donor, Lineage, Cell class and subclass (all cells)	PATL2 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.46e-05	194	140	6	fe36cf5cf8ebd761d29ad23ee074128a12d32031
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIR2DL1 KIR2DL3 KIR2DL4 KIR2DS4 KIR3DL1 KIR3DL2	3.46e-05	194	140	6	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PDLIM7 GYPC ASB2 NOTCH2 NOTCH3	3.46e-05	194	140	6	fdaf61cbe7f77ff5358d150b38adb1fe3778e961
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 PDLIM7 OLFML2B GYPC ROBO2 PRDM6	3.56e-05	195	140	6	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 PDLIM7 OLFML2B GYPC PRDM6 NOTCH3	3.56e-05	195	140	6	2eed0332e338d6f0dbcb399d9d36c4611d491b0a
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	RIN3 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2	3.56e-05	195	140	6	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD248 PDLIM7 GYPC ROBO2 PRDM6 CTXN1	3.56e-05	195	140	6	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	severe_COVID-19-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	OLFML2B SH3BP2 CDH23 EBI3 NOTCH3 SECTM1	3.56e-05	195	140	6	72928a1d987a3a5361c666f3972292aefec5f548
Computational	Neighborhood of IL2RB	KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1 KIR3DL2	1.21e-05	46	71	5	GNF2_IL2RB
Drug	D-Au	STK36 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	8.48e-10	77	136	9	CID000277822
Drug	Aa1	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DL4 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DL2	1.68e-09	83	136	9	CID009549188
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRIM25 AKAP8 MYO1C PDLIM7 KDM5C SH3BP2 CACNA1H WDFY3 NOTCH2 PRRC2B	3.24e-07	198	136	10	3332_DN
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TRIM25 SH3BP2 CCDC88C NFRKB SHARPIN CACNA1H NOTCH2 NOTCH3 SECTM1	3.20e-06	199	136	9	3574_DN
Drug	Ab-9	KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	6.74e-06	21	136	4	CID006540280
Drug	glycoluril	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2	1.61e-05	53	136	5	CID000062347
Drug	1xa5	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4	2.02e-05	93	136	6	CID000157684
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	PPRC1 DLGAP4 ARHGEF11 HEG1 SHARPIN NOTCH2 DMTN PSD4	2.15e-05	193	136	8	948_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	LARP6 SH3BP2 ARHGEF11 TLK1 HEG1 NFRKB WDFY3 NOTCH3	2.32e-05	195	136	8	2283_DN
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	TRIM25 PDLIM7 DLGAP4 ARHGEF11 CBL NFRKB OTUD4 NOTCH2	2.32e-05	195	136	8	6706_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	LARP6 SH3BP2 FXYD5 CNOT4 NOTCH1 NOTCH2 DMTN SECTM1	2.49e-05	197	136	8	3836_DN
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A	CNKSR1 PDLIM7 KDM5C ITIH2 SHARPIN PTCH2 CNOT4 SECTM1	2.49e-05	197	136	8	2809_UP
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A	TRIM25 PDLIM7 SH3BP2 DLGAP4 TNRC6B CACNA1H PSD4 SECTM1	2.58e-05	198	136	8	2272_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; MCF7; HT_HG-U133A	OLFML2B SH3BP2 MUC5B HES2 CBL NFATC4 DMBT1 IMPG2	2.58e-05	198	136	8	2214_UP
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	PPRC1 MUC5B ARHGEF11 CBL TMEM132A NFRKB DMBT1 NOTCH3	2.68e-05	199	136	8	4294_DN
Drug	Cinoxacin [28657-80-9]; Up 200; 15.2uM; HL60; HT_HG-U133A	DLGAP4 ADGRB1 ITIH2 NFATC4 TMEM132A MMP11 BICC1 DMTN	2.78e-05	200	136	8	2722_UP
Drug	Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ADGRB1 FXYD5 ARHGEF11 CBL ITIH2 KSR1 NCAN WDFY3	2.78e-05	200	136	8	4837_UP
Drug	6-carboxyfluorescein diacetate	KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2	2.96e-05	30	136	4	CID000151095
Drug	p-terphenyl	STK36 TRIM25 GYPC KIR3DL1 GOLGA3 TP53	3.62e-05	103	136	6	CID000007115
Drug	NSC237521	CSF2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 TP53	3.93e-05	210	136	8	CID000428410
Disease	central nervous system cancer (implicated_via_orthology)	HES2 NOTCH1 NOTCH2 NOTCH3	1.17e-08	7	128	4	DOID:3620 (implicated_via_orthology)
Disease	adenocarcinoma (implicated_via_orthology)	NOTCH1 NOTCH2 NOTCH3	2.76e-06	7	128	3	DOID:299 (implicated_via_orthology)
Disease	brain cancer (implicated_via_orthology)	PROX2 NOTCH1 NOTCH2 NOTCH3	4.69e-06	26	128	4	DOID:1319 (implicated_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	KIR2DL4 KIR2DS4 KIR3DL2	1.70e-05	12	128	3	EFO_0008197
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3 KIR2DL4	3.49e-05	15	128	3	EFO_0801746
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	5.59e-05	3	128	2	OBA_2042107
Disease	mean corpuscular hemoglobin concentration	TICRR AKAP8 RPN1 DLGAP4 TNRC6B TGIF1 MYPOP ZSCAN10 GYPC NCAN SHARPIN OTUD4 AFF1 TP53 IMPG2	9.23e-05	1105	128	15	EFO_0004528
Disease	Malignant neoplasm of skin	NOTCH1 NOTCH2 TP53 NOTCH3	1.28e-04	59	128	4	C0007114
Disease	Skin Neoplasms	NOTCH1 NOTCH2 TP53 NOTCH3	1.28e-04	59	128	4	C0037286
Disease	malaria (is_implicated_in)	GYPC KIR3DL1 KIR3DS1	1.51e-04	24	128	3	DOID:12365 (is_implicated_in)
Disease	prostate carcinoma, breast carcinoma, ovarian carcinoma	CD248 ARHGEF5 CCDC88C	2.16e-04	27	128	3	EFO_0000305, EFO_0001075, EFO_0001663
Disease	pappalysin-1 measurement	USP34 RPN1	2.77e-04	6	128	2	EFO_0802845
Disease	colorectal cancer (implicated_via_orthology)	NOTCH1 NOTCH2 NOTCH3	2.97e-04	30	128	3	DOID:9256 (implicated_via_orthology)
Disease	intestinal cancer (implicated_via_orthology)	NOTCH1 NOTCH2 NOTCH3	3.61e-04	32	128	3	DOID:10155 (implicated_via_orthology)
Disease	Aortic valve calcification	NOTCH1 TP53	3.87e-04	7	128	2	C0428791
Disease	juvenile myelomonocytic leukemia (is_implicated_in)	CBL CSF2	3.87e-04	7	128	2	DOID:0050458 (is_implicated_in)
Disease	Uterine Cervical Neoplasm	NOTCH1 NOTCH2 TP53	4.71e-04	35	128	3	C0007873
Disease	acute myeloid leukemia (is_implicated_in)	CBL CSF2 TP53 DNMT3B	4.98e-04	84	128	4	DOID:9119 (is_implicated_in)
Disease	Giant Cell Glioblastoma	NOTCH1 NOTCH2 TP53 NOTCH3	4.98e-04	84	128	4	C0334588
Disease	multiple myeloma (is_marker_for)	CBL NOTCH2 TP53	5.13e-04	36	128	3	DOID:9538 (is_marker_for)
Disease	proteoglycan 3 measurement	USP34 RPN1	5.14e-04	8	128	2	EFO_0802970
Disease	autism spectrum disorder (implicated_via_orthology)	TMPRSS9 KDM5C DLGAP4 SHANK3 WDFY3	5.40e-04	152	128	5	DOID:0060041 (implicated_via_orthology)
Disease	breast cancer, ovarian carcinoma	RIN3 ARHGEF5 CCDC88C	5.56e-04	37	128	3	EFO_0001075, MONDO_0007254
Disease	Liver Diseases, Parasitic	ROBO2 TP53	6.59e-04	9	128	2	C0023897
Disease	acquired immunodeficiency syndrome (is_implicated_in)	KIR2DL1 KIR3DS1	6.59e-04	9	128	2	DOID:635 (is_implicated_in)
Disease	Glioma	PTCH2 TP53	6.59e-04	9	128	2	cv:C0017638
Disease	Neoplasm of uncertain or unknown behavior of breast	NOTCH1 NOTCH2 TP53	7.53e-04	41	128	3	C0496956
Disease	Breast adenocarcinoma	NOTCH1 NOTCH2 TP53	7.53e-04	41	128	3	C0858252
Disease	Squamous cell carcinoma of esophagus	NOTCH1 NOTCH2 TP53 NOTCH3	7.93e-04	95	128	4	C0279626
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	TNRC6B TP53	8.21e-04	10	128	2	EFO_1000650, HP_0000131
Disease	interleukin-6 measurement, response to stimulus	ELAPOR2 MUC16	1.00e-03	11	128	2	EFO_0004810, GO_0050896
Disease	cancer (implicated_via_orthology)	CBX6 PROX2 NOTCH1 NOTCH2 TP53 NOTCH3	1.14e-03	268	128	6	DOID:162 (implicated_via_orthology)
Disease	basal cell carcinoma (is_implicated_in)	PTCH2 TP53	1.20e-03	12	128	2	DOID:2513 (is_implicated_in)
Disease	Sarcoma, Spindle Cell	CSF2 TP53	1.64e-03	14	128	2	C0205945
Disease	Sarcoma, Epithelioid	CSF2 TP53	1.64e-03	14	128	2	C0205944
Disease	alcohol use disorder (implicated_via_orthology)	KDM5C NOTCH1 NOTCH2 NOTCH3 PSD4	1.64e-03	195	128	5	DOID:1574 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of bladder	NOTCH1 NOTCH2	1.89e-03	15	128	2	C0496930
Disease	Benign neoplasm of bladder	NOTCH1 NOTCH2	1.89e-03	15	128	2	C0154017
Disease	Carcinoma in situ of bladder	NOTCH1 NOTCH2	1.89e-03	15	128	2	C0154091
Disease	Psoriasis	REL CSF2 TP53	1.97e-03	57	128	3	C0033860
Disease	Pustulosis of Palms and Soles	REL CSF2 TP53	1.97e-03	57	128	3	C0030246
Disease	Squamous cell carcinoma	NOTCH1 NOTCH2 TP53 NOTCH3	2.12e-03	124	128	4	C0007137
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	TNRC6B TP53	2.73e-03	18	128	2	EFO_1000649, HP_0000131
Disease	Carcinoma of bladder	NOTCH1 NOTCH2	2.73e-03	18	128	2	C0699885
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B NOTCH1	2.74e-03	64	128	3	DOID:4947 (is_marker_for)
Disease	macrophage inflammatory protein 1b measurement	TBC1D3 ARHGAP23 TBC1D3B TBC1D3F	2.96e-03	136	128	4	EFO_0008219
Disease	Juvenile Myelomonocytic Leukemia	CBL CSF2	3.04e-03	19	128	2	C0349639
Disease	sexual dimorphism measurement	CD248 RTN4 DLGAP4 POM121L2 CSF2 NFATC4 ALPK3 OTUD4 HERC1 TASOR PRDM6 TP53	3.19e-03	1106	128	12	EFO_0021796
Disease	Crohn's disease	USP34 KSR1 CSF2 AKAP11 NOTCH1 NOTCH2 IMPG2	3.19e-03	441	128	7	EFO_0000384
Disease	Bladder Neoplasm	NCAN NOTCH1 NOTCH2 TP53	3.29e-03	140	128	4	C0005695
Disease	CCL4 measurement	TBC1D3 TBC1D3F	3.37e-03	20	128	2	EFO_0004751
Disease	base metabolic rate measurement	TLK1 GOLGA3	3.37e-03	20	128	2	EFO_0007777
Disease	Malignant neoplasm of urinary bladder	NCAN NOTCH1 NOTCH2 TP53	3.37e-03	141	128	4	C0005684
Disease	Precursor B-cell lymphoblastic leukemia	AFF1 TP53	3.71e-03	21	128	2	C1292769
Disease	Sarcoma	CSF2 TP53	3.71e-03	21	128	2	C1261473
Disease	basophil count, eosinophil count	RIN3 RPN1 CSF2 SHARPIN ASB2	4.09e-03	241	128	5	EFO_0004842, EFO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLFTETSPTSAPWDP	AAAS	516	Q9NRG9
WLSSPCSSDSPPRPS	nan	241	Q9N2K0
LPETVSPSAPSWREP	CBX6	296	O95503
DWPLSSPSPMDAPSV	EIF2AK3	681	Q9NZJ5
TPWPSPPSSYLTIDL	DNMT3B	156	Q9UBC3
VPPAASSEPLSTPWN	AKAP8	211	O43823
ATSLNTPVSYPPWTP	ADGRG4	1811	Q8IZF6
TPVSYPPWTPSSATL	ADGRG4	1816	Q8IZF6
PPWTPSSATLPSLTS	ADGRG4	1821	Q8IZF6
DVPSSSAPPQLGPWS	ADGRB1	891	O14514
PWTRSTAPPESSPAR	ASB2	66	Q96Q27
SPTTPWTPELQGPTS	ARHGEF5	936	Q12774
ALWLPSPAPTAAPTA	CD248	656	Q9HCU0
PSADPWSPIPSGTVL	EPN3	341	Q9H201
KPTPSSNASPWSEPA	A2ML1	1176	A8K2U0
CFRESASPSPEPWTP	SH3BP2	296	P78314
SSPSWPAVDLAPLAP	ALPK3	41	Q96L96
PTPSVISVTSHPWDP	ARHGEF11	1236	O15085
PPSTPLVPSRASSEW	AKAP11	1101	Q9UKA4
YTELQPTSPTPTWPA	FXYD5	51	Q96DB9
QSPSSGTPSPTLWAP	BICC1	486	Q9H694
GTPSPTLWAPPLANT	BICC1	491	Q9H694
MSATWTLSPEPLPPS	CTXN1	1	P60606
SSNRSWTPPRGPSPT	CDH23	2806	Q9H251
SLPPPDPWLETSSSS	DLGAP4	776	Q9Y2H0
TPSSSPGTARTPPVW	MUC5B	3876	Q9HC84
AVPSLPATVPAWPSE	OTUD4	586	Q01804
PATVPAWPSEPTTFG	OTUD4	591	Q01804
TGNPSNSWPSPTEPS	KIR2DS2	221	P43631
TGNPSSSWPSPTEPS	KIR3DL2	316	P43630
WEPLSGPSTPSPVAA	FCHO1	836	O14526
WPSRPSVEKTSPPSS	MUC16	8841	Q8WXI7
WPSPLSVEKNSPPSS	MUC16	9421	Q8WXI7
TPSPESPDQWSSSSP	NOTCH2	2416	Q04721
IGNPSNSWPSPTEPS	KIR2DL2	221	P43627
TGNPSNSWPSPTEPS	KIR2DS4	221	P43632
TPSPESPDQWSSSSP	NOTCH1	2511	P46531
PAVPPTWRASQPSLT	MAGED4	366	Q96JG8
SSWLPSSPARSPSPA	NFRKB	216	Q6P4R8
VVPDSTPSWANPSPT	ITIH2	661	P19823
TGNPSNSWPSPTEPS	KIR2DL3	221	P43628
PASSWPTAAPLPCDS	HES2	71	Q9Y543
LGSPSDPSFSPVSWS	HERC1	3481	Q15751
DSPPWQLESSDPASP	CCDC88C	1431	Q9P219
TGNPSSSWPSPTEPS	KIR3DL1	316	P43629
PTFSWLPLKTSPPSS	PCYT1B	336	Q9Y5K3
PSTDTLSAASLPWPP	KSR1	196	Q8IVT5
QSAPPSSPLSPNWVS	FAM205BP	216	Q63HN1
SPEHWASPSPPSLSD	NOTCH3	2251	Q9UM47
LPSRWASRSPSAPPA	KIAA0408	661	Q6ZU52
LSPNASPCTSPWSSP	LARP6	371	Q9BRS8
TGNPSNSWPSPTEPS	KIR2DS3	221	Q14952
SDASTPWSSSPSPLP	HEG1	706	Q9ULI3
PWSSSPSPLPVSLTT	HEG1	711	Q9ULI3
APAPSWPLSSSVPSQ	TP53	86	P04637
SLSSWTPLEPATASP	GOLGA3	1456	Q08378
TEAPAPASSTPQEPW	PDLIM7	196	Q9NR12
WAGDLPSSSSRPLPP	ELAPOR2	46	A8MWY0
PLPTSESPFAWSPLA	GTSE1	61	Q9NYZ3
LPLLPFSSPSSPWSS	GRIN3A	161	Q8TCU5
SSAAAAAPPPELPEW	PRDM6	226	Q9NQX0
PSSSWPSPTEPSFKT	KIR2DL4	221	Q99706
RDSPFPWSQVPSSSP	PROX2	36	Q3B8N5
LSPIPFWPTFPSTSS	PATL2	106	C9JE40
ISAPARSPSPSTQPW	CSF2	16	P04141
RNPVPAWSPPTTTTD	IGSF23	11	A1L1A6
SSWESEAAPEPAAPP	DACT3	326	Q96B18
LLSHPPEASPLSWTP	DMRTC2	156	Q8IXT2
SPPPPVDWKTYTSSD	GAS2L2	316	Q8NHY3
LKSPSLPAPSPGWTS	BCL9	921	O00512
LPSPSSSPQPHWIAS	CRAMP1	1131	Q96RY5
CSWTLPPAPNSTSPV	EBI3	46	Q14213
LLALPAPSPAPATSW	MAN2C1	931	Q9NTJ4
SQAPSPWLTPDPASV	DENND4B	1331	O75064
SGPSASDPWTPAPAF	EPN1	361	Q9Y6I3
PKVPVSAPSSSDPWT	CBL	596	P22681
SPNSTAWPLSLEPDP	GYPC	6	P04921
PLDPASTTAPAPWAA	FCRLB	291	Q6BAA4
PASLRSSPCAPWGPS	CACNA1H	1121	O95180
QSRPTPSPDTWPTSH	DMBT1	836	Q9UGM3
QSRPTPSPDTWPTSH	DMBT1	1096	Q9UGM3
SASQSQPTPSPDTWP	DMBT1	1351	Q9UGM3
ASQSQPTPSPDTWPT	DMBT1	1481	Q9UGM3
PTPSPDTWPTSRAST	DMBT1	1486	Q9UGM3
TSPPPSPEVWADSRS	DMTN	91	Q08495
PSARSSPASSPELPW	FAM53C	246	Q9NYF3
TGNPSNSWPSPTEPS	KIR2DL1	221	P43626
ASSPPANATAPPLRW	PRRT3	446	Q5FWE3
SLPDPSWDFSPPSFL	PPRC1	201	Q5VV67
PPSFLETSSPKLPSW	PPRC1	211	Q5VV67
PLPPTSDATSPTSRW	RIN3	261	Q8TB24
TGNPSNSWPSPTEPS	KIR2DS1	221	Q14954
WHAALPSSPAPAPAT	MMP11	51	P24347
APERQPSWDPSPVSS	RTN4	101	Q9NQC3
SPWSLDPASASPEPV	SOHLH1	166	Q5JUK2
LPSSPAWSPPATEAT	TMEM132A	776	Q24JP5
SWLLLSAPGPTPASP	NFATC4	246	Q14934
PAPDEPPWSPAATSS	PTCH2	1176	Q9Y6C5
TGNPSSSWPSPTEPS	KIR3DS1	316	Q14943
PLEATVSAPSPAPWE	NCAN	606	O14594
TLAPCPWRSPASSPE	PSD4	431	Q8NDX1
TWAPAPGSASSEAPP	RPN1	16	P04843
ASSLPSPLQPSWSCP	SHARPIN	341	Q9H0F6
WPSADESITSSIPPL	IMPG2	421	Q9BZV3
IWSASPPRAPRSSTP	TBC1D3L	401	B9A6J9
WSSALPQPSTSDPSI	OLFML2B	371	Q68BL8
TSPTLPVTDTTWPPS	POM121L2	471	Q96KW2
ELSLSSPPSPEPDWT	STK36	901	Q9NRP7
SPPPLSWGKSDSSRP	TASOR	1651	Q9UK61
SWPPPLTAIHTPSTA	AFF1	366	P51825
DLSSNPSPGPSPAWT	CNKSR1	326	Q969H4
PSPGPSPAWTDSASL	CNKSR1	331	Q969H4
ASLSPWPKSPPSTTA	C10orf67	356	Q8IYJ2
SSPQTSSDWPTAPEP	CNOT4	356	O95628
TICLWESVPPTPPSA	SLC49A3	211	Q6UXD7
IWSASPPRAPRSSTP	TBC1D3B	401	A6NDS4
IWSASPPRAPRSSTP	TBC1D3H	401	P0C7X1
PPAPWSSLATPSALL	TGIF1	61	Q15583
EGPPSWSQLSTSPTP	TLK1	11	Q9UKI8
PPVSSAAPKPTSWAA	YTHDF3	226	Q7Z739
SWSSAPCPSLPQVPD	USP43	751	Q70EL4
SSGSAAPPTPAPDHW	nan	71	Q8N377
SSPQGPSPWPEESSR	ZSCAN10	166	Q96SZ4
TPSPFQTDGVPWTPS	TICRR	1656	Q7Z2Z1
LTSESSLPSPWGTPA	WDFY3	791	Q8IZQ1
SAELWTPDSEPTPRP	SECTM1	206	Q8WVN6
PTPTLAPKRAWPSDT	RNF208	56	Q9H0X6
PAPSSVLVPHSSQPW	SPEM2	416	Q0P670
LASPAFSPRSPAWIP	SHANK3	1156	Q9BYB0
IWSASPPRAPRSSTP	TBC1D3F	401	A6NER0
PTSALPSDPRSPAAW	ARHGAP23	211	Q9P227
PADVWTPPARASAPS	TRIM25	86	Q14258
DISKPWIPSSPAPSS	TNKS1BP1	266	Q9C0C2
ASPEPPGPESSSRWL	TNKS1BP1	671	Q9C0C2
LWSPVSNPSSPDFTP	TMEM131	1706	Q92545
TDPSPSWPASSGSPT	TMEM131	1771	Q92545
SPTGTPPRAWATRSP	nan	141	Q9UF83
MAPAPAAPSTAWPTS	TMPRSS9	446	Q7Z410
AAPSTAWPTSPESPV	TMPRSS9	451	Q7Z410
AWPTSPESPVVSTPT	TMPRSS9	456	Q7Z410
QPSSEPEWTPEPRSS	PRRC2B	911	Q5JSZ5
YNSTSISVSWDPPPP	ROBO2	751	Q9HCK4
IWSASPPRAPRSSTP	TBC1D3E	401	A0A087X179
PLPSSSWSSVAHPTP	REL	406	Q04864
VSSPAWASSPTPPSG	PRR33	161	A8MZF0
APTWLSPTEPATEAP	VASN	376	Q6EMK4
RPAASESPSAAPTWP	UCN2	41	Q96RP3
IWSASPPRAPRSSTP	TBC1D3D	401	A0A087WVF3
APSPWSPAASPQSSD	USP34	511	Q70CQ2
SSPSNHWLYPSPPLT	PRR30	111	Q53SZ7
IWSASPPRAPRSSTP	TBC1D3G	401	Q6DHY5
IWSASPPRAPRSSTP	TBC1D3	401	Q8IZP1
SSWSLPASPAPDPPD	WNK4	71	Q96J92
LSQCPWSSLPTTSPP	WNK4	876	Q96J92
IWSASPPRAPRSSTP	TBC1D3K	401	A0A087X1G2
IWSASPPRAPRSSTP	TBC1D3I	401	A0A087WXS9
IWSASPPRAPRSSTP	TBC1D3C	401	Q6IPX1
SWGPSLSPTPSEAPK	ZNF692	121	Q9BU19
TNPKPSSPWSSTAPR	TNRC6B	1606	Q9UPQ9
ADPTWTLRFSPSPPK	UTF1	196	Q5T230
LPWASSSPTSTPALG	FAM53A	236	Q6NSI3
SSPRPNPTSSPLLAW	KDM5C	1221	P41229
WPSSSDTTPSPPGTT	MUC12	1586	Q9UKN1
QSWPSSSDTTPSPPG	MUC12	3141	Q9UKN1
SWPNSKDTTPAPPTT	MUC12	3391	Q9UKN1
TSWPTPPPALREASE	MYO1C	831	O00159
SSSPEPWARPSCTPQ	MYPOP	176	Q86VE0